Clinical Trial Update: PET/CT Imaging of Angiogenesis in Patients With Neuroendocrine Tumors Using 68Ga-NODAGA-E[c(RGDyK)]2 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating PET/CT imaging of angiogenesis in neuroendocrine tumor patients using 68Ga-NODAGA-E[c(RGDyK)]2; study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumors

Drugs mentioned

• 68Ga-NODAGA-E[c(RGDyK)]2 (68Ga-NODAGA-E[c(RGDyK)]2)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Neuroendocrine Tumors | Phase 2 | Status: COMPLETED